Page 6 - Statistical Computing News Today

In a systematic review and meta-analysis, Tao Lin and colleagues investigate the incidence, risk factors and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection.

Statistician, Seibersdorf, Austria Organization: IAEA - International Atomic Energy Agency Country: Austria Field location: Seibersdorf Office: IAEA in...

This cluster randomized clinical trial assesses the effect of a coordinated, multifaceted intervention of assessment, education, and feedback vs usual care on t

Environmental data science is a multi-disciplinary and mature field of research at the interface of statistics, machine learning, information technology, climate and environmental science. The two-part special issue ‘Environmental Data Science’ comprises a set of research articles and opinion pieces led by statisticians who are at the forefront of the field. This editorial identifies and discusses common strands of research that appear in the contributions to Part 1, which largely focus on s...

Milwaukee, WI (PRWEB) February 15, 2023 -- Research being presented at the 2023 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI)

As readers of The Lancet Regional Health – Western Pacific, along with the fact that measles outbreaks have been warned of perfect storm of conditions for within 2022 by UNICEF and WHO, we pay a significant interest to the content of the paper entitled “Measles outbreak in the Philippines: Epidemiological and clinical characteristics of hospitalized children, 2016–2019” published earlier within the same journal.1,2 However, upon reproducing the results, we suspect that the authors has ma...

In a prospective cohort study including more than 360,000 people in Hong Kong, Dr. Andrea Luk and colleagues explore age-specific risk factors for all-cause and cause-specific mortality in type 2 diabetes.

Investigating the association between hemoglobin/red blood cell distribution ratio and heart failure 3-month readmission in Chinese elderly patients.

Australia commenced its COVID-19 vaccine program for children aged 12–15 years from July 2021 and for children aged 5–11 years from January 2022 with two primary doses of either Comirnaty (Pfizer–BioNTech BNT162b2, 10 μg for 5–11 years and 30 μg for 12–15 years) or Spikevax (Moderna mRNA-1273, 50 μg for 6–11 years and 100 μg for 12–15 years), 8 weeks apart. A booster dose is recommended for those aged 5–15 years with complex health conditions or severe immunocompromise.

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads rapidly and insidiously. Coronavirus disease 2019 (COVID-19) screening is an important means of blocking community transmission in China, but the costs associated with testing are high. Quarantine capacity and medical resources are also threatened. Therefore, we aimed to evaluate different screening strategies to balance outbreak control and consumption of resources. A community network of 2000 people, co...